SCHEMBL1013843

SCHEMBL1013843

COC(=O)c1cc(Cl)ccc1NC(=O)CSCC(=O)Nc1ccccc1Oc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.60
TDP1 Q9NUW8 1/20 0.60
TP53 P04637 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.53
ALDH1A1 P00352 3/20 0.52
GAA P10253 2/20 0.51
LMNA P02545 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
MAPT P10636 2/20 0.49
ALOX12 P18054 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GPR55 Q9Y2T6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013705 0.90 L3MBTL1 (0.64) L3MBTL1TDP1TP53MAPK1HTT
SCHEMBL1013966 0.88 L3MBTL1 (0.60) L3MBTL1TDP1MAPK1HTTALDH1A1
SCHEMBL1016218 0.83 KDM4E (0.60) L3MBTL1TP53ALDH1A1GAALMNA
SCHEMBL1016077 0.78 POLB (0.60) L3MBTL1TDP1MAPK1HTTALDH1A1
SCHEMBL3784326 0.76 KDM4E (0.62) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL417055 0.74 SERPINE1 (0.80) L3MBTL1MAPK1ALDH1A1LMNAMEN1
SCHEMBL1015300 0.74 ALDH1A1 (0.59) HTTALDH1A1GAALMNAMEN1
SCHEMBL1013563 0.74 KMT2A (0.53) L3MBTL1TDP1ALDH1A1LMNAMEN1
SCHEMBL1800427 0.73 SERPINE1 (0.64) ALDH1A1LMNAHSD17B10
SCHEMBL420909 0.73 NPSR1 (0.56) TP53MAPK1HTTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 L3MBTL1 2670/4885TDP1 1762/4885TP53 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.